Signal Notes

Editorial signal briefings on Korean equities, sector momentum, and machine-tracked follow-through.

signal EN Uncategorized 2026-09-24

Haoxi Health (HAO) Volume Surges 10.9x as Deep-Value Signals Flash

HAO volume spiked to 10.9x its 20-day average, but a -0.87x operating cash flow/net income ratio and a rising dollar (DXY +2.1%) cloud the deep-value setup in this unclassified China ad-tech name.

Chain signal:HAO:2026-09-23
자동 생성 콘텐츠 자동 분석으로 생성됐으며 모든 문장을 사람이 사전 검수한 것은 아닙니다.

Haoxi Health (HAO) Volume Surges 10.9x as Deep-Value Signals Flash

Trading volume in Haoxi Health Technology (HAO) exploded to 10.9 times its 20-day average this session, thrusting a stock that trades at just 0.7x EV/EBITDA and a price-to-book ratio near zero back onto investors' radar as a potential deep-value name in China's online advertising space, even as no company-specific news or earnings event appears to explain the spike.

The sudden burst of activity coincides with a broader trend shift in the stock's price action, and the combination of a rock-bottom valuation, a 22.4% return on equity, and a modest 24% debt ratio gives the setup enough substance to warrant a closer look, even though the stock sits in an unclassified sector with limited analyst coverage.

HAO price chart

Key Facts

Stock nameHAO
TickerHAO
MarketNASDAQ
SectorUnclassified
Volume (x average)10.9x
Signal price$3.16

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China, including short-video marketing services delivered through media partners on platforms such as Toutiao, Douyin, WeChat, and Sina Weibo. The company plans, produces, places, and optimizes online ad campaigns to help advertisers acquire, convert, and retain consumers, with a client base concentrated in the healthcare industry. Founded in 2018, the company is based in Chaoyang, China.

Peer Companies

LZMH, BAOS, CNET, STFS, TC

Risk Factors

The clearest company-specific red flag is earnings quality: operating cash flow runs at -0.87x net income, meaning reported profits are not being converted into cash, which warrants scrutiny before reading too much into the low valuation multiples. As a China-based small-cap ADR operating in an unclassified sector, HAO also carries thinner analyst coverage and less liquidity depth than large-cap peers, which can amplify volatility around volume spikes like this one.

On the macro side, the U.S. 10-year Treasury yield has climbed to 5.11%, up 0.41 percentage points over the past month, while the dollar index (DXY) has risen 2.1% to 101.1 over the same span. Both a rising-rate backdrop and a strengthening dollar tend to weigh on speculative small-cap names and can compress the dollar value of revenue generated by China-based operators, adding a headwind that sits outside the company's direct control.

Recent Disclosures

No disclosures in the past 30 days.

Recent News

Pre-Trade Checklist

Business & competitive edge understood✅ Company profile summarized above
Leading sector⚠️ Not flagged as a leading sector
Good news already priced in?✅ PBR 0.00배 (자산가치 대비 저평가)
Stop-loss / take-profit set✅ Stop-loss -10% / first take-profit +20% set in advance
Exit plan if wrong✅ 10% trailing stop from peak; setup auto-invalidated on a break below key support

Trade Levels

Signal price$3.16
Stop-loss$2.84 (-10% from signal price)
First take-profit$3.79 (+20% from signal price)
Trailing stop10% from peak
InvalidationClose back below key support ($3.03)

This remains a watchlist situation rather than a call to action: the volume surge and depressed valuation multiples are worth tracking, but the earnings-quality gap keeps the setup speculative. For those monitoring it, the reference framework is a signal price of $3.16, a stop-loss at $2.84, and a first take-profit target of $3.79 with a 10% trailing stop thereafter to protect gains if momentum builds; a close back below the $3.03 support level would undercut the thesis entirely.